Deal struck to develop integrin antagonist treatment
Thrombogenics will pay €1 million to Galapagos to further explore integrin antagonists as treatment for diabetic retinopathy.
Powered by Suchmaschinenoptimierung
Our Industry Partners
Empowering Excellence in Ophthalmology
We extend our deepest gratitude to our Platinum, Gold, and Silver partners. Your generous support fuels our mission to advance medical education, advocate for patient safety, and foster breakthrough innovations across West Virginia.
West Virginia Academy of Eye Physicians and Surgeons — advancing quality eye care through education, advocacy, and community awareness.
About
Resources
Advocacy